Profile
| Metric | Value |
|---|---|
| Full Name | Prelude Therapeutics Incorporated |
| Ticker | NASDAQ: PRLD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | preludetx.com |
| Employees | 131 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.02 | ||
| Price, 1D Change | -3.81% | |
| $127M | ||
| - | ||
| - | ||
| 1.48 | ||
| $7M | ||
| Revenue, 1Y Change | +100.00% | |
| -$1.68 | ||
| EPS, 1Y Change | +16.89% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.68 | ||
| EPS Estimate | -$1.27 | |
| EPS Est. Change | +24.30% | |
| $7.00M | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $2.02 | ||
| Price Target | - | $4.00 |
| Price Tgt. Change | - | +98.02% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.04 | -$2.02 | +1.05% | |
| -$1.77 | -$1.68 | +5.48% | |
| -$1.27 | N/A | +24.30% | |
| -$1.15 | N/A | +31.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $1.50M | $7.00M | +366.67% | |
| - | N/A | - | |
| $33.33M | N/A | +376.19% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +119.57% | ||
| -66.16% | ||
| +150.29% | ||
| -55.59% | ||
| +100.00% | ||
| +100.00% | ||
| +16.89% | ||
| +28.50% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.02 | ||
| $1.36 | ||
| SMA 200 vs Price | -32.54% | |
| $2.09 | ||
| SMA 50 vs Price | +3.26% | |
| 1.48 | ||
| $0.23 | ||
| 49.44 | ||
| 122.80% | ||
| 195.45% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $7.00M | ||
| -$1.68 | ||
| $5.23M | ||
| 74.69% | ||
| -$139.71M | ||
| -1,995.91% | ||
| -$127.17M | ||
| -1,816.76% | ||
| -$139.71M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.14 | ||
| 5.30 | ||
| 5.30 | ||
| - | ||
| 4 | ||
| -4.76 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 12.09 | ||
| 2.17 | ||
| -0.75 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $131.46M | ||
| $12.47M | ||
| $175.52M | ||
| $135.90M | ||
| $44.06M | ||
| $25.64M | ||
| $18.03M | ||
| $2.70M | ||
| $7.73M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $146.71M | ||
| $146.71M | ||
| $1.77M | ||
| $28.72M | ||
| $1.77M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$102.89M | ||
| $90.19M | ||
| -$120.00K | ||
| $764.00K | ||
| -$103.65M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| Citizens Capital Markets | → | |
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with PRLD
FAQ
What is the ticker symbol for Prelude Therapeutics Incorporated?
The ticker symbol for Prelude Therapeutics Incorporated is NASDAQ:PRLD
Does Prelude Therapeutics Incorporated pay dividends?
No, Prelude Therapeutics Incorporated does not pay dividends
What sector is Prelude Therapeutics Incorporated in?
Prelude Therapeutics Incorporated is in the Healthcare sector
What industry is Prelude Therapeutics Incorporated in?
Prelude Therapeutics Incorporated is in the Biotechnology industry
What country is Prelude Therapeutics Incorporated based in?
Prelude Therapeutics Incorporated is headquartered in United States
When did Prelude Therapeutics Incorporated go public?
Prelude Therapeutics Incorporated initial public offering (IPO) was on September 25, 2020
Is Prelude Therapeutics Incorporated in the S&P 500?
No, Prelude Therapeutics Incorporated is not included in the S&P 500 index
Is Prelude Therapeutics Incorporated in the NASDAQ 100?
No, Prelude Therapeutics Incorporated is not included in the NASDAQ 100 index
Is Prelude Therapeutics Incorporated in the Dow Jones?
No, Prelude Therapeutics Incorporated is not included in the Dow Jones index
When was Prelude Therapeutics Incorporated last earnings report?
Prelude Therapeutics Incorporated's most recent earnings report was on November 12, 2025
When does Prelude Therapeutics Incorporated report earnings?
The next expected earnings date for Prelude Therapeutics Incorporated is March 17, 2026
Data Sources & References
- PRLD Official Website preludetx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1678660/000119312525275887/0001193125-25-275887-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1678660/000095017025035921/0000950170-25-035921-index.htm
- PRLD Profile on Yahoo Finance finance.yahoo.com/quote/PRLD
- PRLD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/prld